Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 6FED 1

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Distress Syndrome 1Pneumonia 1Bronchiolitis Obliterans 1

Interventions

stenoparib 1sargramostim 1poly ICLC 1pembrolizumab 1copanlisib 1avelumab 1Yoga 1Temozolomide 1PM 01183 1Immunoglobulins, Intravenous 1Hydroxychloroquine 1Granulocyte-Macrophage Colony-Stimulating Factor 1Ethiodized Oil 1Etanercept 1Celecoxib 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × FED × Etanercept × Clear all
NCT00029328 2015-03-25

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

FDA Office of Orphan Products Development

Phase 1/2 Completed
15 enrolled

Bronchiolitis Obliterans, Pneumonia, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡